Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.

[1]  P. Kellman,et al.  Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[2]  Pierre Croisille,et al.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.

[3]  Michael Jerosch-Herold,et al.  Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease , 2010, Circulation. Cardiovascular imaging.

[4]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[5]  J. Seward,et al.  Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.

[6]  Matthew W. Martinez,et al.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.

[7]  Amyloid heart disease. , 2010, British journal of hospital medicine.

[8]  M. Desai,et al.  Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. , 2009, JACC. Cardiovascular imaging.

[9]  J. Francis,et al.  The role of cardiovascular magnetic resonance imaging in heart failure. , 2009, Journal of the American College of Cardiology.

[10]  P. Hari,et al.  Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up , 2009, BMC medical physics.

[11]  L. Królicki,et al.  Cardiovascular magnetic resonance findings in a case of Danon disease , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[12]  A. Del Maschio,et al.  Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. , 2009, AJR. American journal of roentgenology.

[13]  W. Manning,et al.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. , 2009, The American journal of cardiology.

[14]  J. Schulz-Menger,et al.  Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. , 2009, Journal of the American College of Cardiology.

[15]  D. Pennell,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Cardiovascular Magnetic Resonance and Prognosis in Cardiac Amyloidosis , 2022 .

[16]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[17]  Michael Jerosch-Herold,et al.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[18]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[19]  H. Kauczor,et al.  Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[20]  F. Prato,et al.  Feasibility of the single‐bolus strategy for measuring the partition coefficient of Gd‐DTPA in patients with myocardial infarction: Independence of image delay time and maturity of scar , 2006, Magnetic resonance in medicine.

[21]  J. Seidman,et al.  Glycogen storage diseases presenting as hypertrophic cardiomyopathy. , 2005, The New England journal of medicine.

[22]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[23]  Gerald Wisenberg,et al.  Determining the extent to which delayed‐enhancement images reflect the partition‐coefficient of Gd‐DTPA in canine studies of reperfused and unreperfused myocardial infarction , 2004, Magnetic resonance in medicine.

[24]  J. Seward,et al.  Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. , 2004, The American journal of cardiology.

[25]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[26]  C. Lorenz,et al.  Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. , 2001, Radiology.

[27]  C. Higgins,et al.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.

[28]  J. Carroll,et al.  Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. , 1982, The American journal of cardiology.